MedTrace Logo

The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery

NCT00732849 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2008-08-12

No results posted yet for this study

Summary

The study was designed to test the hypothesis that immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients following elective upper GI surgery

Conditions

  • Gastrointestinal Surgery

Interventions

DRUG

Reconvan, Dipeptiven, Omegaven

Reconvan (1ml=1 kcal), 30 kcal/kg b.w. Omegaven 1 ml/ kg b.w. Dipeptiven 1 ml/ kg b.w.

Sponsors & Collaborators

  • Jagiellonian University

    lead OTHER

Principal Investigators

  • Stanislaw Klek, MD, PhD · Jagiellonian University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2002-09-30
Completion
2007-11-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00732849 on ClinicalTrials.gov